Views & Analysis The patient segmentation model Dividing patients into groups based on how they behave towards their condition aids understanding.
News GSK asthma hope depemokimab works in second indication GSK's experimental IL-5 inhibitor depemokimab has shown its potential in a pair of phase 3 trials in patients with chronic rhinosinusitis with nasal polyps (CRSwNP).
Sales & Marketing Sponsored Global reach, personal touch: Mastering customer engagement ... In today's interconnected pharma market, the ability to scale engagement across borders is essential for survival and growth.
